Subjective and Objective Methods of Assessing Walking Limitation Due to Claudication
The Estimation of Ambulation Capacity by History Questionnaire (EACH-Q): An Assessment of Its Validity and Inter-day Reproducibility in Patients With Vascular-type Claudication
1 other identifier
observational
37
1 country
2
Brief Summary
Leg artery disease is a common condition in which fatty deposits develop in the blood vessels that supply the legs. Many patients with leg artery disease experience a cramp-like leg pain during walking that is relieved by rest; this is called intermittent claudication. To help determine the severity of leg artery disease, patients may be questioned about how far they can walk before claudication pain forces them to stop. However, this information is usually of limited use because most patients poorly estimate their walking capacity. The investigators have developed a simple questionnaire to help estimate walking capacity in patients with leg artery disease. The purpose of this study is to test the validity and reliability of this questionnaire. By validity, the investigators mean the extent to which the questionnaire measures what it is supposed to measure (walking capacity). By reliability, the investigators mean the extent to which the questionnaire produces the same results over time when completed on two different days. The investigators hypothesise that the investigators simple questionnaire will be valid and reliable.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2011
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 24, 2011
CompletedFirst Posted
Study publicly available on registry
December 2, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedMay 15, 2012
November 1, 2011
11 months
November 24, 2011
May 14, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Treadmill maximum walking distance
2 weeks
EACH-Q walking questionnaire score
2 weeks
Secondary Outcomes (4)
WIQ walking questionnaire score
2 weeks
Self-reported maximum walking distance
2 weeks
6-minute maximum walking distance
2 weeks
GPS-measured maximum walking distance
2 weeks
Study Arms (1)
Intermittent claudication
Eligibility Criteria
Patients with intermittent claudication recruited from hospital clinics
You may qualify if:
- ankle-brachial pressure index \<0.9 on one or both legs
- presence of leg artery disease with exertional leg symptoms (claudication)
- age 18-90 years
You may not qualify if:
- inability to provide written, informed consent
- medical conditions that make exercise testing unsafe (e.g. unstable angina)
- comorbidities that limit walking performance to a greater extent than claudication symptoms
- unable to complete the tests involved in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sheffield Teaching Hospitals NHS Foundation Trustlead
- Sheffield Hallam Universitycollaborator
- University Hospital, Angerscollaborator
- Imperial College Londoncollaborator
Study Sites (2)
Sheffield Hallam University
Sheffield, South Yorkshire, S10 2BP, United Kingdom
Sheffield Vascular Institute
Sheffield, South Yorkshire, S5 7AU, United Kingdom
Related Publications (1)
Tew G, Copeland R, Le Faucheur A, Gernigon M, Nawaz S, Abraham P. Feasibility and validity of self-reported walking capacity in patients with intermittent claudication. J Vasc Surg. 2013 May;57(5):1227-34. doi: 10.1016/j.jvs.2012.02.073. Epub 2013 Feb 4.
PMID: 23384490DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Garry A Tew, PhD
Sheffield Hallam University
- PRINCIPAL INVESTIGATOR
Pierre Abraham, MD, PhD
University Hospital of Angers, France
- PRINCIPAL INVESTIGATOR
Shah Nawaz, MD
Sheffield Teaching Hospitals NHS Foundation Trust
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 24, 2011
First Posted
December 2, 2011
Study Start
June 1, 2011
Primary Completion
May 1, 2012
Study Completion
May 1, 2012
Last Updated
May 15, 2012
Record last verified: 2011-11